BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer
HEALTH

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

File photo

-/-

First colorectal cancer patient treated with individualized mRNA cancer vaccine, German biopharmaceutical company says

  • News Service 01 OCTOBER 2021, 04:03AA
  • BioNTech
  • Phase
  • mRNA
  • vaccine
SON DAKİKA

#title#